Cretescu L, Beare A S, Schild G C
Infect Immun. 1978 Nov;22(2):322-7. doi: 10.1128/iai.22.2.322-327.1978.
Antibodies to type A influenza virus matrix protein (M) were assayed by single radial diffusion in 180 paired sera of volunteers challenged intranasally with live H3N2 viruses of varying degrees of virulence. Of these volunteers 20 had had severe clinical reactions (influenza-like); there had been 19 moderate reactions (lesser degrees of constitutional illness), and the remaining 141 reactions had been graded mild, very mild, or nil. Only 2 volunteers were shown to have antibodies to M in the pre-trial serum samples, and 11 developed anti-M rises after virus inoculation. Nine of the 11 had had severe reactions, and 2 had had moderate reactions. There was, therefore, a clear correlation between severity of clinical illness and anti-M antibody formation. In general, anti-M increases coincided with increases to the hemagglutinins and nucleoprotein, and with virus shedding. However, no anti-M antibody could be demonstrated in paired sera of 18 additional volunteers of whom 12 had developed severe reactions after the inoculation of virulent H0N1 and H1N1 influenza A viruses and of whom 12 had shown laboratory evidence of infection.
通过单向辐射扩散法,对180对经鼻接种不同毒力活H3N2病毒的志愿者血清进行了甲型流感病毒基质蛋白(M)抗体检测。这些志愿者中,20人出现了严重临床反应(类似流感);19人出现中度反应(较轻程度的全身性疾病),其余141人的反应被评为轻度、非常轻度或无反应。仅2名志愿者的试验前血清样本显示有M抗体,11人在病毒接种后出现抗M抗体升高。这11人中,9人有严重反应,2人有中度反应。因此,临床疾病严重程度与抗M抗体形成之间存在明显相关性。一般来说,抗M抗体增加与血凝素和核蛋白抗体增加以及病毒排出同时出现。然而,在另外18名志愿者的配对血清中未检测到抗M抗体,其中12人在接种强毒H0N1和H1N1甲型流感病毒后出现严重反应,且12人有实验室感染证据。